E55.9
Conditions
Interventions
Group 1: Test group: 63 periodontitis patients with Stage III
Group/Cohort Description: Participants in this group will undergo a clinical assessment to determine their vitamin D levels using a Chairs
Sponsors
Universitätsmedizin Mainz
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Healthy subjects aged 18-80 years Untreated stage III periodontitis Non-smokers No inflammatory oral mucosal diseases = 14 teeth at the time of the periodontal examination No vitamin D supplementation in the last 6 months
Exclusion criteria
Exclusion criteria: Periodontal treatment in the last six months Known or ongoing abuse of drugs, medication, or alcohol , Pregnancy , Impaired kidney function, type 1 or type 2 diabetes, liver diseases, cardiovascular diseases, Vitamin D intake
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The clinical study is based on the central hypothesis that vitamin D, with its various roles in the immune system, inflammation, and bone metabolism, may have a significant impact on the development and progression of chronic inflammatory periodontal disease. Therefore, it is hypothesized that patients with periodontitis will have lower vitamin D levels compared to periodontally healthy individuals | — |
Countries
Germany
Contacts
Public ContactAdrian Kasaj
Universitätsmedizin Mainz
Outcome results
None listed